Found: 3
Select item for more details and to access through your institution.
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02356-0
- By:
- Publication type:
- Article
Clinical and economic impact of 'ROS1-testing' strategy compared to a 'no-ROS1-testing' strategy in advanced NSCLC in Spain.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00417-z
- By:
- Publication type:
- Article